Evidence map›Paper›PMID 41079828›Full record

ArticleClinical case reports2025

A Case of an Acquired Factor V Inhibitor Triggered by Levofloxacin and Ceftazidime and Effectively Treated With Clinical Pharmacist Assistance.

Chunjuan Zhao, Weibu Chen, Xueyan Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chunjuan ZhaoLaboratory Department, Shenzhen People's Hospital, The First Affiliated Hospital Southern University of Science and Technology Shenzhen P.R. China.
Weibu ChenLaboratory Department, Shenzhen People's Hospital, The First Affiliated Hospital Southern University of Science and Technology Shenzhen P.R. China.
Xueyan ChenClinical Laboratory, Department of Clinical Laboratory Shenzhen Longhua District People's Hospital Shenzhen P.R. China.ORCID https://orcid.org/0000-0002-5435-0888

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired factor V inhibitor is a rare and clinically challenging condition that can manifest across a spectrum ranging from asymptomatic laboratory abnormalities to life-threatening hemorrhagic episodes. This case reports a patient with antibiotic-associated AFVI, who presents asymptomatically and may be managed conservatively with close monitoring and clinical pharmacist guidance.

Indexed as

acquired factor V inhibitorsasymptomaticclinical pharmacistcoagulopathyself‐recovery

Identifiers

PMID41079828
PMCPMC12507529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.